Develops drugs for multiple sclerosis and amyotrophic lateral sclerosis.
Jun 2026Revenue $920K/yrExpenses $12.8M/yr
No trendCash runway ≈ 2.8 years from Jun 2026
Figures by year
When will Medicinova be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $920K and expenses $12.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $410K | $13.7M | −$13.3M |
| Dec 2023 | $1.00M | $10.9M | −$9.90M |
| Dec 2021 | $4.04M | $14.3M | −$10.2M |
| Dec 2012 | $803K | $11.7M | −$10.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.